Studies have shown that CCN2/CTGF induces cardiomyocyte hypertrophy and apoptosis during the pathological process of DCM, and CCN2/CTGF may serve as a sensitive biomarker for the early diagnosis of DCM and potentially play a protective role in myocardial injury (39). The gene discussed is CCN2; the disease is familial dilated cardiomyopathy.